Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Mc-MMAD is monomethyl auristatin D (MMAD) modified with the protective group maleimidocaproyl (Mc). MMAD is a potent tubulin microtubule inhibitor that suppresses cancer cell proliferation and is commonly employed as a toxic payload in ADC synthesis.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $98 | In Stock | |
| 5 mg | $243 | In Stock | |
| 10 mg | $388 | In Stock | |
| 25 mg | $639 | In Stock | |
| 50 mg | $898 | In Stock | |
| 100 mg | $1,190 | In Stock | 
| Description | Mc-MMAD is monomethyl auristatin D (MMAD) modified with the protective group maleimidocaproyl (Mc). MMAD is a potent tubulin microtubule inhibitor that suppresses cancer cell proliferation and is commonly employed as a toxic payload in ADC synthesis.  | 
| Molecular Weight | 964.26 | 
| Formula | C51H77N7O9S | 
| Cas No. | 1401963-15-2 | 
| Smiles | [H][C@]([C@@H](C)CC)([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)C=CC1=O)C(C)C | 
| Relative Density. | 1.168 g/cm3 (Predicted) | 
| Color | White | 
| Appearance | Solid | 
| Storage | The compound is unstable in solution. Please use soon | Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature. | 
| Solubility Information | DMSO: ≥ 80 mg/mL, Sonication is recommended.   | 
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (2.07 mM), Sonication is recommended.  Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.